Reliability and validity of the Calgary Depression Scale for Schizophrenia (CDSS) in youth at clinical high risk for psychosis

Schizophrenia Research

Volumn 153, Issue 1-3, 2014, Pages 64-67

  Addington, Jean ^a   Shah, Hely ^b   Liu, Lu ^a   Addington, Donald ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Calgary depression scale for schizophrenia; Clinical high risk; Depression; Psychosis; Schizophrenia

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CALGARY DEPRESSION SCALE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; DYSPHORIA; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR DEPRESSION; MALE; MOOD DISORDER; MORBIDITY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEGATIVE SYNDROME; POSITIVE SYNDROME; PRIORITY JOURNAL; PSYCHOSIS; RELIABILITY; SCALE OF PRODROMAL SYMPTOM; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; VALIDITY; CANADA; COMPLICATION; DEPRESSION; LONGITUDINAL STUDY; PREDICTIVE VALUE; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; REPRODUCIBILITY; RISK; SCHIZOPHRENIA; STATISTICS; YOUNG ADULT;

ADOLESCENT; ADULT; CANADA; DEPRESSION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; REPRODUCIBILITY OF RESULTS; RISK; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; STATISTICS AS TOPIC; YOUNG ADULT;

EID: 84895820550     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2013.12.014     Document Type: Article

References (28)

1. Addington J., Heinssen R. Prediction and prevention of psychosis in youth at clinical high risk. Annu. Rev. Clin. Psychol. 2011, 8:269-289.
2. Addington D., Addington J., Schissel B. A depression rating scale for schizophrenics. Schizophr. Res. 1990, 3(4):247-251.
3. Addington D., Addington J., Maticka-Tyndale E., Joyce J. Reliability and validity of a depression rating scale for schizophrenics. Schizophr. Res. 1992, 6(3):201-208.
4. Addington D., Addington J., Maticka-Tyndale E. Assessing depression in schizophrenia: the Calgary depression scale. Br. J. Psychiatry 1993, 163(Suppl. 22):39-44.
5. Addington D., Addington J., Maticka-Tyndale E. Specificity of the Calgary Depression Scale for schizophrenics. Schizophr. Res. 1994, 11(3):239-244.
6. Addington D., Addington J., Atkinson M. A psychometric comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale. Schizophr. Res. 1996, 19(2-3):205-212.
7. Addington J., Cadenhead K.S., Cornblatt B.A., Mathalon D.H., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Woods S.W., Addington J.A., Cannon T.D. North American Prodrome Longitudinal Study (NAPLS 2): overview and recruitment. Schizophr. Res. 2012, 142(1-3):77-82.
8. Addington J., McGregor L., Marulanda D., Raedler T. Recruitment strategies for the detection of individuals at clinical high risk of developing psychosis. Epidemiol. Psychiatr. Sci. 2012, 31:1-5.
9. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry 1961, 4:561-571.
10. Bernard D., Lancon C., Auquier P., Reine G., Addington D. Calgary depression scale for schizophrenia: a study of the validity of a French-language version in a population of schizophrenic patients. Acta Psychiatr. Scand. 1998, 97:36-41.
11. Collaborative Working Group on Clinical Trial Evaluations Atypical antipsychotics for treatment of depression in schizophrenia and affective disorders. J. Clin. Psychiatry 1998, 59(Suppl. 12):41-45.
12. Collins A., Remington G., Coulter K., Birkett K. Depression in schizophrenia: a comparison of three measures. Schizophr. Res. 1996, 20:205-209.
13. First M., Spitzer R.L., Gibbon M., Williams B., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders 1995, Biometrics Research Department, New York State Psychiatric Institute, New York: New York. Patient edition.
14. Fulford D., Niendam T.A., Floyd E.G., Carter C.S., Mathalon D.H., Vinogradov S., Stuart B.K., Loewy R.L. Symptom dimensions and functional impairment in early psychosis: more to the story than just negative symptoms. Schizophr. Res. 2013, 147(1):125-131.
15. Fusar-Poli P., Nelson B., Valmaggia L., Yung A.R., McGuire P.K. Comorbid depressive and anxiety disorders in 509 individuals with an at-risk mental state: impact on psychopathology and transition to psychosis. Schizophr. Bull. 2014, 40:120-131.
16. Häfner H., Maurer K., Trendler G., an der Heiden W., Schmidt M. The early course of schizophrenia and depression. Eur. Arch. Psychiatry Clin. Neurosci. 2005, 255(3):167-173.
17. Harvey P.D. Mood symptoms, cognition, and everyday functioning: in major depression, bipolar disorder, and schizophrenia. Innov. Clin. Neurosci. 2011, 8:14-18.
18. Lancon C., Auquier P., Reine G., Toumi M., Addington D. Evaluation of depression in schizophrenia: psychometric properties of a French version of the Calgary Depression Scale. Psychiatry Res. 1999, 89:123-132.
19. Lancon C., Auquier P., Reine G., Bernard D., Toumi M. Study of the concurrent validity of the Calgary Depression Scale for Schizophrenics (CDSS). J. Affect. Disord. 2000, 58:107-115.
20. McGlashan T., Walsh B.C., Woods S.W. The Psychosis-Risk Syndrome: Handbook for Diagnosis and Follow-up 2010, Oxford University Press, New York.
21. Müller M.J. Overlap between emotional blunting, depression, and extrapyramidal symptoms in schizophrenia. Schizophr. Res. 2002, 57:307-309.
22. Müller M.J., Marx-Dannigkeit P., Schlosser R., Wetzel H., Addington D., Benkert O. The calgary depression rating scale for schizophrenia: development and interrater reliability of a German version (CDSS-G). J. Psychiatr. Res. 1999, 33:433-443.
23. Piskulic D., Addington J., Cadenhead K., Cannon T., Cornblatt B., Heinssen R., Perkins D., Seidman L., Tsuang M., Walker E., Woods S., McGlashan T. Negative symptoms in individuals at clinical high risk of psychosis. Psychiatry Res. 2012, 196:220-224.
24. Rietdijk J., Ising H.K., Dragt S., Klaassen R., Nieman D., Wunderink L., Cuijpers P., Linszen D., van der Gaag M. Depression and social anxiety in help-seeking patients with an ultra-high risk for developing psychosis. Psychiatry Res. 2013, 209:309-313.
25. Sanchez-Gistau V., Baeza I., Arango C., González-Pinto A., de la Serna E., Parellada M., Graell M., Paya B., Llorente C., Castro-Fornieles J. Predictors of suicide attempt in early-onset, first-episode psychoses: a longitudinal 24-month follow-up study. J. Clin. Psychiatry 2013, 74(1):59-66.
26. Sarro S., Duenas R.M., Ramirez N., Arranz B., Martinez R., Sanchez J.M., Gonzalez J.M., Salo L., Miralles L., San L. Cross-cultural adaptation and validation of the Spanish version of the Calgary depression scale for schizophrenia. Schizophr. Res. 2004, 68:349-355.
27. Siris S.G. Depression in schizophrenia: perspective in the era of "Atypical" antipsychotic agents. Am. J. Psychiatry 2000, 157(9):1379-1389.
28. Yung A.R., Buckby J.A., Cotton S.M., Cosgrave E.M., Killackey E.J., Stanford C., Godfrey K., McGorry P.D. Psychotic-like experiences in nonpsychotic help-seekers: associations with distress, depression, and disability. Schizophr. Bull. 2006, 32:352-359.